Meanwhile, the levels of CD8+ T cell effector molecules GZMB and IFN‐γ within tumor microenvironment (TME) also dramatically increased in RA‐treated group (Figure 3G,H; Figure S4C,D, Supporting Information), implying that RA enhances the activation of effective T cells in vivo. Here, CD8A is linked to neoplasm.